These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26795693)

  • 41. On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective.
    Chien RN
    J Gastroenterol Hepatol; 2010 May; 25(5):852-7. PubMed ID: 20546437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
    Locarnini S; Warner N
    Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of hepatitis B patients with antiviral resistance.
    Fung SK; Lok AS
    Antivir Ther; 2004 Dec; 9(6):1013-26. PubMed ID: 15651760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Modern strategy in the treatment of chronic hepatitis B: progress and prospects].
    Isakov VA
    Eksp Klin Gastroenterol; 2007; (2):107-12. PubMed ID: 17539354
    [No Abstract]   [Full Text] [Related]  

  • 46. Molecular virology of hepatitis B virus and targets for antiviral intervention.
    Glebe D; König A
    Intervirology; 2014; 57(3-4):134-40. PubMed ID: 25034480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term results of treatment with nucleoside and nucleotide analogues (entecavir and tenofovir) for chronic hepatitis B.
    Asselah T; Marcellin P
    Clin Liver Dis; 2013 Aug; 17(3):445-50. PubMed ID: 23905815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tenofovir plus entecavir as rescue therapy for multidrug-resistant chronic hepatitis B.
    Scotto G; D'Addiego G; Giammario A; Campanale F; Fazio V
    Liver Int; 2012 Jan; 32(1):171-2. PubMed ID: 22098064
    [No Abstract]   [Full Text] [Related]  

  • 50. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
    Liaw YF
    Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic hepatitis B: preventing, detecting, and managing viral resistance.
    Keeffe EB; Dieterich DT; Pawlotsky JM; Benhamou Y
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):268-74. PubMed ID: 18328434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B].
    Lin Q; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):722-5. PubMed ID: 19874684
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of chronic hepatitis B: current challenges and future directions.
    Chin R; Locarnini S
    Rev Med Virol; 2003; 13(4):255-72. PubMed ID: 12820187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Viral hepatitis: towards the eradication of HCV and a cure for HBV.
    Asselah T; Marcellin P
    Liver Int; 2015 Jan; 35 Suppl 1():1-3. PubMed ID: 25529080
    [No Abstract]   [Full Text] [Related]  

  • 55. Antiviral therapy for chronic hepatitis B.
    Jafri SM; Lok AS
    Clin Liver Dis; 2010 Aug; 14(3):425-38. PubMed ID: 20638023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic hepatitis B: a treatment update.
    Wong VW; Chan HL
    Semin Liver Dis; 2013 May; 33(2):122-9. PubMed ID: 23749668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy.
    Bourne EJ; Dienstag JL; Lopez VA; Sander TJ; Longlet JM; Hall JG; Kwiatkowski RW; Wright T; Lai CL; Condreay LD
    J Viral Hepat; 2007 Jan; 14(1):55-63. PubMed ID: 17212645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug resistance in antiviral therapy.
    Locarnini S; Bowden S
    Clin Liver Dis; 2010 Aug; 14(3):439-59. PubMed ID: 20638024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The genetic variability and clinical significance of hepatitis B virus].
    Tang H; Chen EQ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):161-3. PubMed ID: 19554777
    [No Abstract]   [Full Text] [Related]  

  • 60. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Bourlière M
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.